FDA is investigating reports of hair loss, aspiration, and suicidal thoughts among people taking the medications

Authors dub the term benzodiazepine-induced neurological dysfunction to describe neurological complications

Implementation of training session increased proportion of patients with documented Abnormal Involuntary Movement Score

Protective effect suggested with female gender for schizophrenia patients with tardive dyskinesia

69.9 percent of sample reported acute physical health effects; 2.3 percent reported need for subsequent medical attention

Findings show physical, mental, and cognitive symptoms one year after ICU stay for COVID-19